Why some real-world users exceed trial averages Conversely, some individuals outperform trial averages
The higher the number, the harder it is for the energy to reach its preferred destination
Stanford, who has been prescribing Wegovy to her patients since it was first available in 2021, says that technically a patient with a body mass index (BMI) of 30 or higher or a patient with a BMI of 27, plus an obesity-related illness [like high blood pressure], would meet the criteria for these medications. There are other additional factors, like whether a patient is responsive to the medication (some people are not), what other things they have done to attempt to lose weight, whether their insurance will cover the drug, and if they have the means to pay out of pocket (without insurance, the drugs can run upwards of $1,500 a monthdefinitely not cheap)
Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C
Obesity is more complicated than a simple imbalance of the hormone mimicked by these drugs, but doctors do now generally consider it a chronic disease